Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study - Sorbye, H; Welin, S; Langer, SW (Ann Oncol, 2013)
et al.